What Rita Wilson's Story Can Help Us Understand About Breast Cancer and Second Opinions

The third pathologist

In April 2015 Rita Wilson gave a statement to People, quoted by Variety, describing what had just happened to her. It is one of the most specific accounts a public figure has given of a diagnosis, and every step in it is worth reading.

She had a known underlying condition, lobular carcinoma in situ, which she said had been monitored with yearly mammograms and breast MRIs. Two surgical breast biopsies then found a further in situ change. "I was relieved when the pathology showed no cancer," she wrote.

Then: "However, a friend who had had breast cancer suggested I get a second opinion on my pathology and my gut told me that was the thing to do. A different pathologist found invasive lobular carcinoma. His diagnosis of cancer was confirmed by, yet, another pathologist."

She had a bilateral mastectomy and reconstruction, and said she expected to make a full recovery. "Why? Because I caught this early, have excellent doctors and because I got a second opinion."

That statement is the whole public record used here.

In situ and invasive are different words for a reason

NCI draws the line clearly. When abnormal cells are still inside the ducts or lobules and have not spread into surrounding breast tissue, that is carcinoma in situ. Once they have spread into the tissue around them, and can reach lymph nodes or other organs, the cancer is invasive.

Lobular carcinoma in situ, or LCIS, sits in an unusual place. NCI states that LCIS is not breast cancer, but that it raises the risk of developing breast cancer later. That is why it is watched rather than treated as cancer, and it is why Wilson was having yearly imaging in the first place.

The finding that changed everything for her was the word invasive.

Why lobular cancer is the harder one to catch

Most breast cancers begin in the ducts that carry milk toward the nipple. NCI describes invasive lobular carcinoma as beginning instead in the lobules, the glands that make milk, and notes three things about it: it grows more slowly, it is less common than invasive ductal carcinoma, and it is more often found in both breasts than other types are.

Wilson's own account shows where the difficulty sits. She was under yearly mammograms and breast MRIs, she had two surgical biopsies, and the first pathology reading still said no cancer. The imaging was not what caught it. A second reading of the tissue was.

None of that makes lobular cancer untreatable. It does mean that "the scans were clear" answers a narrower question than most people assume. Our page on breast cancer types covers the differences.

What a pathology second opinion actually is

This is the part of Wilson's story that people generalize wrongly. She did not get a second opinion on a treatment recommendation. She got a second opinion on a laboratory reading.

A pathologist looks at slides of the removed tissue under a microscope and decides what the cells are. That is a judgment, made by a person, about patterns. Distinguishing a lobular change confined to the lobule from one that has begun to invade is exactly the kind of call where experienced readers can disagree.

Asking for the slides to be reviewed elsewhere is a routine request. Cancer centers do it as a matter of course when a patient arrives from outside, and it does not require anyone to fall out with their first doctor. Our page on pathology reports explains what the document says and where the ambiguity usually lives.

The scale of the disease

For 2026, ACS projects 321,910 new US cases of female breast cancer and 42,140 deaths, and SEER reprints those numbers. SEER measures the survival side itself: 91.9% at five years across all stages, for people diagnosed between 2016 and 2022.

That figure is high because most breast cancers are found before they have travelled far. It is an average across a very large group over past years, and it describes no individual.

When to get checked

For a change you have noticed, ask for diagnostic evaluation, not routine screening. Book an appointment for:

• A lump, or an area of thickening that feels different from the rest of the breast
• A part of one breast that has changed in texture or firmness without a lump
• Skin dimpling, puckering, redness or scaling
• A nipple turning inward, or new discharge, especially from one side
• A change in the size or shape of one breast
• Pain in one fixed spot that does not follow your cycle

And for a result you have already been given, these are fair questions: what exactly did the pathologist see, is the finding in situ or invasive, and can the slides be reviewed by a second pathologist. Our guide for people newly diagnosed with breast cancer covers the sequence.

What this does not mean

• Wilson's account describes her own pathology in 2015. Nothing here describes her current health.
• One case in which a second reading changed the answer does not mean first readings are usually wrong. Most are not.
• A second opinion is a reasonable request, not an accusation. It is also not obligatory.
• LCIS is not cancer. Having it does not mean cancer will follow.
• A clear mammogram does not settle a change you can feel. Those are different questions, answered by different tests.

Sources

• Variety, Rita Wilson Reveals Breast Cancer Diagnosis, Double Mastectomy, quoting her statement to People — https://variety.com/2015/biz/people-news/rita-wilson-breast-cancer-double-mastectomy-1201472059/
• NCI, What Is Breast Cancer? — https://www.cancer.gov/types/breast/what-is-breast-cancer
• NCI, Types of Breast Cancer — https://www.cancer.gov/types/breast/breast-cancer-types
• NCI, Breast Changes and Conditions — https://www.cancer.gov/types/breast/breast-changes
• SEER Cancer Stat Facts, Female Breast Cancer — https://seer.cancer.gov/statfacts/html/breast.html

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.